Most Cited Papers In Last Two Years

Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

Autophagy-related mechanisms for treatment of multiple myeloma

Targeting BCL2 pathways in CLL: a story of resistance and ingenuity

Supramolecular host-guest nanosystems for overcoming cancer drug resistance

Emerging roles of 3D-culture systems in tackling tumor drug resistance

Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies

Unlocking antitumor immunity with adenosine receptor blockers

Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance

Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity

Drug resistance in glioblastoma: from chemo- to immunotherapy

Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia

A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer

Emerging resistance vs. losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia

A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer